Exchange: NASDAQ·Updated 07:34 PM EDT
BNTX logo

BNTXBioNTech SE - ADR

$92.33
$0.17
(0.18%)
Today
Closed $92.33
$0.00
(0.00%)
After Hours
EarningsAug 4
Mkt Cap$23.35B
Vol696,992.00

About

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
7,807

Frequently Asked Questions

What is Market Cap of BioNTech SE - ADR?
What is the 52-week high for BioNTech SE - ADR?
What is the 52-week low for BioNTech SE - ADR?
What is BioNTech SE - ADR stock price today?
What was BioNTech SE - ADR stock price yesterday?
What is the PE ratio of BioNTech SE - ADR?
What is the Price-to-Book ratio of BioNTech SE - ADR?
What is the 50-day moving average of BioNTech SE - ADR?
How many employees does BioNTech SE - ADR have?

Advertisement|Remove ads.